BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37459556)

  • 21. Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma.
    Zhen N; Zhu J; Mao S; Zhang Q; Gu S; Ma J; Zhang Y; Yin M; Li H; Huang N; Wu H; Sun F; Ying B; Zhou L; Pan Q
    Cell Mol Gastroenterol Hepatol; 2023; 16(5):735-755. PubMed ID: 37478905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of survivin in hepatoblastoma after chemotherapy.
    Uehara S; Oue T; Kawatsu M; Nara K; Fukuzawa M
    Eur J Pediatr Surg; 2013 Oct; 23(5):400-4. PubMed ID: 23444076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase separation of YAP mediated by coiled-coil domain promotes hepatoblastoma proliferation via activation of transcription.
    Mao S; Liu Q; Wu H; Zhu J; Xie Y; Ma J; Zhen N; Pan Q
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1398-1407. PubMed ID: 36908026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
    Pire A; Hirsch TZ; Morcrette G; Imbeaud S; Gupta B; Pilet J; Cornet M; Fabre M; Guettier C; Branchereau S; Brugières L; Guerin F; Laithier V; Coze C; Nagae G; Hiyama E; Laurent-Puig P; Rebouissou S; Sarnacki S; Chardot C; Capito C; Faure-Conter C; Aerts I; Taque S; Fresneau B; Zucman-Rossi J
    Eur J Cancer; 2024 Mar; 200():113583. PubMed ID: 38330765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
    Zhou S; Parham DM; Yung E; Pattengale P; Wang L
    Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
    Zhang W; Meyfeldt J; Wang H; Kulkarni S; Lu J; Mandel JA; Marburger B; Liu Y; Gorka JE; Ranganathan S; Prochownik EV
    J Biol Chem; 2019 Nov; 294(46):17524-17542. PubMed ID: 31597698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic progenitor cells in liver cancers from Asian children.
    Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
    Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mediating role of coagulation function on the association of prenatal exposure to aflatoxin B1 and postpartum hemorrhage in Guangxi, China.
    Chen J; Ye Y; Huang D; Pan D; Qiu X; Lei L; Luo X; Li J; Wu K; Xiao S; Liu S; Zeng X
    Environ Sci Pollut Res Int; 2022 May; 29(25):37543-37555. PubMed ID: 35066843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
    Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
    J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of
    Beck A; Trippel F; Wagner A; Joppien S; Felle M; Vokuhl C; Schwarzmayr T; Strom TM; von Schweinitz D; Längst G; Kappler R
    Clin Epigenetics; 2018; 10():27. PubMed ID: 29507645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nur77 inhibition of β-catenin expression mediates Hepatoblastoma progression and enhances cisplatin's therapeutic effect.
    Zhou J; Liu X; Yin H; Zhou Y; Xu Z; Zhou K; Li T; Fang Y; Shen Q
    Gene; 2024 May; 908():148292. PubMed ID: 38369247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
    Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
    Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma.
    Beck A; Eberherr C; Hagemann M; Cairo S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    Cancer Biol Ther; 2016 Nov; 17(11):1168-1176. PubMed ID: 27635950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA expression might predict prognosis of epithelial hepatoblastoma.
    Gyugos M; Lendvai G; Kenessey I; Schlachter K; Halász J; Nagy P; Garami M; Jakab Z; Schaff Z; Kiss A
    Virchows Arch; 2014 Apr; 464(4):419-27. PubMed ID: 24570391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.
    Rugge M; Sonego F; Pollice L; Perilongo G; Guido M; Basso G; Ninfo V; Pennelli N; Gambini C; Guglielmi M; Fabiano A; Leandro G; Keeling JW
    Liver; 1998 Apr; 18(2):128-33. PubMed ID: 9588772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line.
    Marchese S; Sorice A; Ariano A; Florio S; Budillon A; Costantini S; Severino L
    Toxins (Basel); 2018 Oct; 10(11):. PubMed ID: 30373285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACLY-β-catenin axis modulates hepatoblastoma cell proliferation.
    Lin Y; Fang H; Ma C; Zhou J; Ding M; Sun H; Xu Y; Shan Y; Gao H; Yang L; Gu S; Li H
    Biochem Biophys Res Commun; 2023 Jun; 663():104-112. PubMed ID: 37121120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.